1. A practical guide to Bayesian group sequential designs1. (24th August 2013) Authors: Gsponer, Thomas; Gerber, Florian; Bornkamp, Björn; Ohlssen, David; Vandemeulebroecke, Marc; Schmidli, Heinz; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bayesian analysis for nonlinear mixed‐effects models under heavy‐tailed distributions. (16th September 2013) Authors: De la Cruz, Rolando; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bayesian approach to the design and analysis of non‐inferiority trials for anti‐infective products1. (5th August 2013) Authors: Gamalo, Meg A.; Tiwari, Ram C.; LaVange, Lisa M.; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bayesian methods for design and analysis of safety trials1. (30th July 2013) Authors: Price, Karen L.; Amy Xia, H.; Lakshminarayanan, Mani; Madigan, David; Manner, David; Scott, John; Stamey, James D.; Thompson, Laura; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bayesian Methods in Medical Product Development and Regulatory Reviews. (10th January 2014) Authors: Price, Karen; LaVange, Lisa; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bayesian modeling of cost‐effectiveness studies with unmeasured confounding: a simulation study. (13th November 2013) Authors: Stamey, James D.; Beavers, Daniel P.; Faries, Douglas; Price, Karen L.; Seaman,, John W.; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Flexible shrinkage estimation of subgroup effects through Dirichlet process priors. Issue 6 (1st November 2016) Authors: Gamalo-Siebers, Margaret; Tiwari, Ram; LaVange, Lisa Journal: Journal of biopharmaceutical statistics Issue: Volume 26:Issue 6(2016) Page Start: 1040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis. (30th August 2013) Authors: Ohlssen, David; Price, Karen L.; Amy Xia, H.; Hong, Hwanhee; Kerman, Jouni; Fu, Haoda; Quartey, George; Heilmann, Cory R.; Ma, Haijun; Carlin, Bradley P.; Price, Karen; LaVange, Lisa Journal: Pharmaceutical statistics Issue: Volume 13:Number 1(2014:Jan./Feb.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inference and Decision Making for 21st-Century Drug Development and Approval. (29th March 2019) Authors: Ruberg, Stephen J.; Harrell, Frank E.; Gamalo-Siebers, Margaret; LaVange, Lisa; Jack Lee, J.; Price, Karen; Peck, Carl Journal: American statistician Issue: Volume 73(2019)Supplement 1 Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials Tomorrow. (2nd January 2022) Authors: McMillan, Gianna; Mayer, Cristiana; Tang, Rui; Liu, Yi; LaVange, Lisa; Antonijevic, Zoran; Beckman, Robert A. Journal: Statistics in biopharmaceutical research Issue: Volume 14:Number 1(2022) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗